Trial
NCT02557945
Gabapentin in Patients at Clinical Risk for Psychosis
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
New York State Psychiatric Institute
Collaborators
—
Condition
Clinical High Risk for Psychosis
Intervention
Gabapentin
Why stopped
Combination of insufficient funding and lack of compelling findings
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-05-03